Cigna (CGN) Stock Forecast & Price Target

10 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CGN Analyst Ratings

Moderate Buy

13 Buy

5 Hold

0 Sell

Based on 18 analysts giving stock ratings to

Cigna

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CGN Stock 12 Month Forecast

Average Price Target

€296.16

▲(23.92% Upside)

Based on 18 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is €296.16 with a high forecast of €332.45 and a low forecast of €253.05. The average price target represents a 23.92% change from the last price of €239.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"205":"€205","237":"€237","269":"€269","301":"€301","333":"€333"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":332.44912809,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€332.45</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":296.1604861941176,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€296.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":253.0452681,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€253.05</span>\n  </div></div>","useHTML":true}}],"tickPositions":[205,237,269,301,333],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,242.169,249.1136252376923,256.0582504753846,263.00287571307695,269.9475009507692,276.89212618846153,283.83675142615385,290.7813766638462,297.72600190153844,304.67062713923076,311.6152523769231,318.5598776146154,325.50450285230767,{"y":332.44912809,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,242.169,246.32219124570136,250.4753824914027,254.62857373710406,258.78176498280544,262.9349562285068,267.08814747420814,271.2413387199095,275.39452996561084,279.5477212113122,283.70091245701354,287.8541037027149,292.00729494841625,{"y":296.1604861941176,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,242.169,243.00563600769232,243.84227201538462,244.67890802307693,245.51554403076923,246.35218003846154,247.18881604615385,248.02545205384615,248.86208806153846,249.69872406923076,250.53536007692307,251.37199608461538,252.20863209230768,{"y":253.0452681,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":251.205,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":241.866,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.852,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":232.477,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.204,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":225.795,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.152,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":228.278,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.127,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.074,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.081,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":245.053,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.169,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€332.45

Average Price Target€296.16

Lowest Price Target€253.05

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Charles Rhyee

TD Cowen

€294.93

Buy

23.40%

Upside

Reiterated

09/16/26

Analysts Offer Insights on NA Companies: Generac Holdings (NYSE: GNRC) and Cigna (NYSE: CI)

Stephen Baxter

Wells Fargo

€267.88

Hold

12.08%

Upside

Reiterated

09/15/26

Wells Fargo Sticks to Its Hold Rating for Cigna (CI)

Lance Wilkes

Bernstein

€332.45

Buy

39.10%

Upside

Reiterated

09/09/26

Cigna (CI) Gets a Buy from Bernstein

Elizabeth Anderson CFA

Evercore ISI

€253.05

Hold

5.88%

Upside

Initiated

09/09/26

Cigna initiated with an In Line at Evercore ISICigna initiated with an In Line at Evercore ISI

Jessica Tassan

Piper Sandler

€301.91

Buy

26.32%

Upside

Reiterated

08/26/26

Piper Sandler Remains a Buy on Cigna (CI)

David Windley

Jefferies

€293.18→€267.88

Hold

12.08%

Upside

Downgraded

08/03/26

Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies

Parker Snure

Raymond James

€305.4→€279.22

Buy

16.83%

Upside

Reiterated

08/03/26

Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James

Scott Fidel

Goldman Sachs

€296.67→€307.14

Buy

28.51%

Upside

Reiterated

08/02/26

Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)

Unknown Analyst

Oppenheimer

Not Ranked

Oppenheimer

€318.49

Buy

33.26%

Upside

Reiterated

07/31/26

Oppenheimer Keeps Their Buy Rating on Cigna (CI)

Erin Wright

Morgan Stanley

€315

Buy

31.80%

Upside

Reiterated

07/31/26

Morgan Stanley Sticks to Their Buy Rating for Cigna (CI)

David S Macdonald

Truist Financial

€305.4

Buy

27.78%

Upside

Reiterated

07/31/26

Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Dexcom (DXCM)

George Hill

Deutsche Bank

€263.52→€266.13

Hold

11.35%

Upside

Reiterated

07/31/26

Cigna price target raised to $305 from $302 at Deutsche BankCigna price target raised to $305 from $302 at Deutsche Bank

Michael Ha

Robert W. Baird

€294.06→€315.87

Buy

32.16%

Upside

Reiterated

07/31/26

Cigna price target raised to $362 from $337 at BairdCigna price target raised to $362 from $337 at Baird

Andrew Mok CFA

Barclays

€265.26→€270.5

Hold

13.18%

Upside

Reiterated

07/31/26

Barclays Sticks to Its Hold Rating for Cigna (CI)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

07/30/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Charles Rhyee

TD Cowen

€294.93

Buy

23.40%

Upside

Reiterated

09/16/26

Analysts Offer Insights on NA Companies: Generac Holdings (NYSE: GNRC) and Cigna (NYSE: CI)

Stephen Baxter

Wells Fargo

€267.88

Hold

12.08%

Upside

Reiterated

09/15/26

Wells Fargo Sticks to Its Hold Rating for Cigna (CI)

Lance Wilkes

Bernstein

€332.45

Buy

39.10%

Upside

Reiterated

09/09/26

Cigna (CI) Gets a Buy from Bernstein

Elizabeth Anderson CFA

Evercore ISI

€253.05

Hold

5.88%

Upside

Initiated

09/09/26

Cigna initiated with an In Line at Evercore ISICigna initiated with an In Line at Evercore ISI

Jessica Tassan

Piper Sandler

€301.91

Buy

26.32%

Upside

Reiterated

08/26/26

Piper Sandler Remains a Buy on Cigna (CI)

David Windley

Jefferies

€293.18→€267.88

Hold

12.08%

Upside

Downgraded

08/03/26

Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies

Parker Snure

Raymond James

€305.4→€279.22

Buy

16.83%

Upside

Reiterated

08/03/26

Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James

Scott Fidel

Goldman Sachs

€296.67→€307.14

Buy

28.51%

Upside

Reiterated

08/02/26

Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)

Unknown Analyst

Oppenheimer

Not Ranked

Oppenheimer

€318.49

Buy

33.26%

Upside

Reiterated

07/31/26

Oppenheimer Keeps Their Buy Rating on Cigna (CI)

Erin Wright

Morgan Stanley

€315

Buy

31.80%

Upside

Reiterated

07/31/26

Morgan Stanley Sticks to Their Buy Rating for Cigna (CI)

David S Macdonald

Truist Financial

€305.4

Buy

27.78%

Upside

Reiterated

07/31/26

Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Dexcom (DXCM)

George Hill

Deutsche Bank

€263.52→€266.13

Hold

11.35%

Upside

Reiterated

07/31/26

Cigna price target raised to $305 from $302 at Deutsche BankCigna price target raised to $305 from $302 at Deutsche Bank

Michael Ha

Robert W. Baird

€294.06→€315.87

Buy

32.16%

Upside

Reiterated

07/31/26

Cigna price target raised to $362 from $337 at BairdCigna price target raised to $362 from $337 at Baird

Andrew Mok CFA

Barclays

€265.26→€270.5

Hold

13.18%

Upside

Reiterated

07/31/26

Barclays Sticks to Its Hold Rating for Cigna (CI)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

07/30/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Stocks with the Highest Top Analyst Consensus in the General Sector

STDNStandard Nuclear

SKHYSK Hynix

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

3 Months

Ann HynesMizuho Securities

Success Rate

17/28 ratings generated profit

Average Return

+4.32%

Copying Ann Hynes's trades and holding each position for 3 Months would result in 60.71% of your transactions generating a profit, with an average return of +4.32% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

25/32 ratings generated profit

Average Return

+16.14%

Copying Scott Fidel's trades and holding each position for 1 Year would result in 78.13% of your transactions generating a profit, with an average return of +16.14% per trade.

2 Years

Scott FidelGoldman Sachs

Success Rate

29/32 ratings generated profit

Average Return

+23.42%

Copying Scott Fidel's trades and holding each position for 2 Years would result in 90.63% of your transactions generating a profit, with an average return of +23.42% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CGN Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CGN has received 21 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. CGN average Analyst price target in the past 3 months is 296.16.

Each month's total comprises the sum of three months' worth of ratings.

CGN Financial Forecast

CGN Earnings Forecast

Next quarter’s earnings estimate for CGN is €6.51 with a range of €6.43 to €6.76. The previous quarter’s EPS was €6.75. CGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year CGN has Performed in-line its overall industry.

CGN Sales Forecast

Next quarter’s sales forecast for CGN is €63.00B with a range of €61.14B to €64.41B. The previous quarter’s sales results were €62.09B. CGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year CGN has Performed in-line its overall industry.

CGN Stock Forecast FAQ

What is DE:CGN’s average 12-month price target, according to analysts?

Based on analyst ratings, Cigna Corp’s 12-month average price target is 296.16.

What is DE:CGN’s upside potential, based on the analysts’ average price target?

Cigna Corp has 23.92% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Cigna Corp a Buy, Sell or Hold?

Cigna Corp has a consensus rating of Moderate Buy, which is based on 13 buy ratings, 5 hold ratings and 0 sell ratings.

What is Cigna Corp’s share price target?

The average share price target for Cigna Corp is 296.16. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €332.45 ,and the lowest forecast is €253.05. The average share price target represents 23.92% Increase from the current price of €239.

What do analysts say about Cigna Corp?

Cigna Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.

How can I buy shares of Cigna Corp?

To buy shares of DE:CGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Cigna (CGN) Stock Forecast & Price Target

CGN Analyst Ratings

CGN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cigna

CGN Analyst Recommendation Trends

CGN Financial Forecast

CGN Earnings Forecast

CGN Sales Forecast

CGN Stock Forecast FAQ

Detailed List of Analyst Forecasts